NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Hepatitis Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hepatitis C Virus



Reports from Institute Pasteur advance knowledge in hepatitis C virus



August 6th, 2007

Data detailed in "The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein" have been presented. "Hepatitis C virus (HCV) envelope glycoproteins are highly glycosylated, with up to 5 and 11 N-linked glycans on E1 and E2, respectively. Most of the glycosylation sites on HCV envelope glycoproteins are conserved, and some of the glycans associated with these proteins have been shown to play an essential role in protein folding and HCV entry," investigators in Lille, France report.

"Such a high level of glycosylation suggests that these glycans can limit the immunogenicity of HCV envelope proteins and...


Source: Hepatitis Weekly (2007-08-06)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login